REXAHN PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Non-Exclusive License Agreement, dated as of March 2, 2023, by and between The Trustees of the University of Pennsylvania and the Company
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amended and Restated License Agreement, dated as of June 15, 2022, by and between The Trustees of the University of Pennsylvania and the Company
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amendment No. 4 to Exclusive License Agreement with Know-How, dated as of April 15, 2024, by and among The Trustees of the University of Pennsylvania and The University of Florida...
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amendment No. 3 to Exclusive License Agreement with Know-How, dated as of December 23, 2022, by and among The Trustees of the University of Pennsylvania and The University of...
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amendment No. 2 to Exclusive License Agreement with Know-How, dated as of July 1, 2022, by and among The Trustees of the University of Pennsylvania and The University of Florida...
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Amendment No. 1 to Exclusive License Agreement with Know-How, dated as of May 1, 2020, by and among The Trustees of the University of Pennsylvania and The University of Florida...
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
Exclusive License Agreement with Know-How, dated as of April 10, 2019, by and among The Trustees of the University of Pennsylvania and The University of Florida Research...
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
2025
License Agreement dated June 16, 2021
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
MD
2021
AMENDMENT NO. 2 TO RESEARCH AND EXCLUSIVE LICENSE OPTION AGREEMENT
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2012
Amendment No. 1 to the Research and Exclusive License Option Agreement, dated January 19, 2011, by and between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries...
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2011
Research and Exclusive License Option Agreement, dated as of June 26, 2009, by and between Rexahn Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2009
Research and Exclusive License Option Agreement, dated as of June 26, 2009, by and between Rexahn Pharmaceuticals, Inc. and the license optionee named therein
License Agreements
REXAHN PHARMACEUTICALS, INC.
Biotechnology
NY
2009